Viraday is a combined agent that includes efavirenz, emtricitabine, and tenofovir and is used to treat HIV. The combination of substances included in the composition of a drug significantly simplifies the schedule of using medications and helps patients to strictly observe the time of admission. In addition, the appointment of combined funds prevents the development of resistance (resistance) of the virus to certain substances.